Logo image of BIIB

BIOGEN INC (BIIB) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BIIB - US09062X1037 - Common Stock

174.83 USD
+0.71 (+0.41%)
Last: 1/28/2026, 7:03:11 PM
174.41 USD
-0.42 (-0.24%)
After Hours: 1/28/2026, 7:03:11 PM
Fundamental Rating

6

Overall BIIB gets a fundamental rating of 6 out of 10. We evaluated BIIB against 525 industry peers in the Biotechnology industry. BIIB scores excellent points on both the profitability and health parts. This is a solid base for a good stock. BIIB is valued quite cheap, but it does not seem to be growing. With these ratings, BIIB could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • BIIB had positive earnings in the past year.
  • In the past year BIIB had a positive cash flow from operations.
  • BIIB had positive earnings in each of the past 5 years.
  • BIIB had a positive operating cash flow in each of the past 5 years.
BIIB Yearly Net Income VS EBIT VS OCF VS FCFBIIB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.51%, BIIB belongs to the top of the industry, outperforming 92.19% of the companies in the same industry.
  • BIIB has a Return On Equity of 8.84%. This is amongst the best in the industry. BIIB outperforms 92.38% of its industry peers.
  • With an excellent Return On Invested Capital value of 9.70%, BIIB belongs to the best of the industry, outperforming 94.86% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for BIIB is significantly below the industry average of 18.07%.
Industry RankSector Rank
ROA 5.51%
ROE 8.84%
ROIC 9.7%
ROA(3y)7.52%
ROA(5y)9.06%
ROE(3y)13.45%
ROE(5y)18.41%
ROIC(3y)10.57%
ROIC(5y)13.65%
BIIB Yearly ROA, ROE, ROICBIIB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • BIIB's Profit Margin of 15.98% is amongst the best of the industry. BIIB outperforms 92.57% of its industry peers.
  • BIIB's Profit Margin has declined in the last couple of years.
  • The Operating Margin of BIIB (28.50%) is better than 96.76% of its industry peers.
  • In the last couple of years the Operating Margin of BIIB has declined.
  • Looking at the Gross Margin, with a value of 75.24%, BIIB belongs to the top of the industry, outperforming 83.81% of the companies in the same industry.
  • BIIB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 28.5%
PM (TTM) 15.98%
GM 75.24%
OM growth 3Y-4.87%
OM growth 5Y-12.22%
PM growth 3Y5.99%
PM growth 5Y-16.26%
GM growth 3Y-1.51%
GM growth 5Y-2.23%
BIIB Yearly Profit, Operating, Gross MarginsBIIB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BIIB is still creating some value.
  • BIIB has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, BIIB has less shares outstanding
  • BIIB has a better debt/assets ratio than last year.
BIIB Yearly Shares OutstandingBIIB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
BIIB Yearly Total Debt VS Total AssetsBIIB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

  • BIIB has an Altman-Z score of 3.28. This indicates that BIIB is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.28, BIIB is in the better half of the industry, outperforming 69.14% of the companies in the same industry.
  • BIIB has a debt to FCF ratio of 2.78. This is a good value and a sign of high solvency as BIIB would need 2.78 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 2.78, BIIB belongs to the best of the industry, outperforming 92.95% of the companies in the same industry.
  • A Debt/Equity ratio of 0.35 indicates that BIIB is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.35, BIIB is not doing good in the industry: 68.76% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 2.78
Altman-Z 3.28
ROIC/WACC1.15
WACC8.4%
BIIB Yearly LT Debt VS Equity VS FCFBIIB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

  • BIIB has a Current Ratio of 2.72. This indicates that BIIB is financially healthy and has no problem in meeting its short term obligations.
  • BIIB has a Current ratio of 2.72. This is in the lower half of the industry: BIIB underperforms 68.38% of its industry peers.
  • BIIB has a Quick Ratio of 2.04. This indicates that BIIB is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.04, BIIB is doing worse than 73.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.72
Quick Ratio 2.04
BIIB Yearly Current Assets VS Current LiabilitesBIIB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

3

3. Growth

3.1 Past

  • BIIB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.51%.
  • BIIB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.31% yearly.
  • BIIB shows a small growth in Revenue. In the last year, the Revenue has grown by 4.77%.
  • Measured over the past years, BIIB shows a decrease in Revenue. The Revenue has been decreasing by -7.62% on average per year.
EPS 1Y (TTM)2.51%
EPS 3Y-4.95%
EPS 5Y-13.31%
EPS Q2Q%17.89%
Revenue 1Y (TTM)4.77%
Revenue growth 3Y-4.13%
Revenue growth 5Y-7.62%
Sales Q2Q%2.79%

3.2 Future

  • The Earnings Per Share is expected to grow by 0.59% on average over the next years.
  • BIIB is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.63% yearly.
EPS Next Y-7.36%
EPS Next 2Y-3.15%
EPS Next 3Y-0.51%
EPS Next 5Y0.59%
Revenue Next Year1.98%
Revenue Next 2Y-1.62%
Revenue Next 3Y-1.2%
Revenue Next 5Y-0.63%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BIIB Yearly Revenue VS EstimatesBIIB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B
BIIB Yearly EPS VS EstimatesBIIB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

7

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.44 indicates a reasonable valuation of BIIB.
  • Compared to the rest of the industry, the Price/Earnings ratio of BIIB indicates a rather cheap valuation: BIIB is cheaper than 97.90% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 28.60. BIIB is valued rather cheaply when compared to this.
  • Based on the Price/Forward Earnings ratio of 11.32, the valuation of BIIB can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, BIIB is valued cheaply inside the industry as 98.10% of the companies are valued more expensively.
  • BIIB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.83.
Industry RankSector Rank
PE 10.44
Fwd PE 11.32
BIIB Price Earnings VS Forward Price EarningsBIIB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BIIB indicates a rather cheap valuation: BIIB is cheaper than 98.29% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, BIIB is valued cheaply inside the industry as 98.29% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.34
EV/EBITDA 7.65
BIIB Per share dataBIIB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • BIIB has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.15%
EPS Next 3Y-0.51%

0

5. Dividend

5.1 Amount

  • No dividends for BIIB!.
Industry RankSector Rank
Dividend Yield 0%

BIOGEN INC / BIIB FAQ

Can you provide the ChartMill fundamental rating for BIOGEN INC?

ChartMill assigns a fundamental rating of 6 / 10 to BIIB.


What is the valuation status of BIOGEN INC (BIIB) stock?

ChartMill assigns a valuation rating of 7 / 10 to BIOGEN INC (BIIB). This can be considered as Undervalued.


How profitable is BIOGEN INC (BIIB) stock?

BIOGEN INC (BIIB) has a profitability rating of 7 / 10.


How financially healthy is BIOGEN INC?

The financial health rating of BIOGEN INC (BIIB) is 7 / 10.